PhD Position
Enregistrez cette offre et organisez votre recherche
Créez un compte gratuit pour enregistrer des offres d'emploi, créer des alertes et revenir à cette liste depuis votre tableau de bord.
En continuant, vous acceptez nos Conditions d’utilisation & Politique de confidentialité.
KU Leuven (University of Leuven), founded in 1425, is one of Europe's oldest and most prestigious universities. Ranked among the world's leading research universities and consistently recognized as one of Europe's most innovative institutions, KU Leuven provides an outstanding environment for doctoral training and scientific discovery.
The PhD research will be conducted at the Rega Institute for Medical Research, a multidisciplinary and internationally renowned research center with a strong track record in virology, microbiology, immunology, and the development of innovative therapies for infectious diseases.
The doctoral candidate will join the Molecular, Structural and Translational Virology (MSTV) group. MSTV develops novel antiviral and host‑directed therapeutic strategies through a detailed understanding of viral replication mechanisms and virus‑host interactions. Within MSTV, the team led by Prof. Lieve Naesens studies influenza viruses and coronaviruses, combining expertise in molecular virology, cell biology, antiviral drug discovery, and advanced infection models. The team has discovered multiple first‑in‑class inhibitors targeting viral entry and genome replication and investigates host pathways that can be exploited to broadly combat respiratory virus infections and associated lung disease.
As part of a Marie Skłodowska-Curie Doctoral Network, the successful candidate will work in a highly international and interdisciplinary environment, benefiting from collaborative research projects, network‑wide training activities, and secondments at leading European academic and industrial partner institutions.
Project
Viral infections remain a major threat to global health, as illustrated by recurring influenza epidemics and the risk of future pandemics. New antiviral strategies are urgently needed, particularly approaches that target host pathways rather than viral components, thereby offering broader and more durable protection against diverse viruses. Peroxisomes are emerging as key cellular organelles in this context because they play critical roles in lipid metabolism, innate immunity, and viral replication. Despite their therapeutic potential, progress in this field is hampered by a shortage of researchers trained at the interface of virology and peroxisome biology.
The VirION Doctoral Network addresses this challenge by training 15 Doctoral Candidates in an interdisciplinary and international research programme that integrates virology, organelle biology, systems biology, and innovation.
Within the VirION network, the doctoral candidate at the Rega Institute will investigate how influenza A virus (IAV) remodels peroxisome metabolism and dynamics during infection. The project will combine molecular virology, advanced microscopy, cell biology, and animal infection models to establish when and how peroxisomes are altered during the viral replication cycle. Specific objectives include identifying viral proteins responsible for these changes, validating key findings in infected mouse tissues, and uncovering host factors that could serve as targets for the development of innovative antiviral therapies.
The candidate will be embedded in an international network of academic and industrial partners and will benefit from specialised training, collaborative research projects, and secondments at leading European institutions.
Profile
We are seeking a curious, highly motivated, and collaborative PhD candidate to investigate how influenza viruses manipulate peroxisome metabolism and dynamics during infection, and how these insights can be translated into innovative host‑directed antiviral therapies.
Applicants should have a strong interest in virology, virus‑host interactions, innate immunity, and cellular organelle biology. Experience in mammalian cell culture, virology, molecular biology, microscopy, cell imaging, lipidomics, or metabolomics is an asset. The successful candidate should demonstrate scientific curiosity, a willingness to learn new experimental approaches, and the ability to work effectively in a multidisciplinary and international research environment.
The position includes international secondments and participation in the training, networking, and outreach activities of the VirION Doctoral Network.
Requirements
- Master’s degree (with at least distinction) in biology, biomedical sciences, pharmaceutical sciences, biochemistry, molecular biology, microbiology, or related discipline.
- Excellent written and spoken English communication skills (official proof of English language proficiency is required unless the applicant holds a diploma from an English‑taught programme in Australia, English‑speaking Canada, Ireland, New Zealand, the UK, or the USA).
- Excellent experimental and analytical skills, organised, flexible, open and critical attitude with a multidisciplinar